Evidence map›Paper›PMID 37192443›Full record

ArticleAmerican journal of respiratory and critical care medicine2023

Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease.

Mirco Govoni, Michele Bassi, Debora Santoro, Sinéad Donegan, Dave Singh

Open access · hybridAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mirco GovoniGlobal Clinical Development, Translational and Precision Medicine, Chiesi, Parma, Italy.ORCID 0000-0002-7834-7237
Michele BassiGlobal Clinical Development, Translational and Precision Medicine, Chiesi, Parma, Italy.
Debora SantoroGlobal Clinical Development, Translational and Precision Medicine, Chiesi, Parma, Italy.
Sinéad DoneganAlmac Diagnostics, Craigavon, United Kingdom; and.
Dave SinghMedicines Evaluation Unit, The University of Manchester, Manchester University NHS Foundation Hospital Trust, Manchester, United Kingdom.
Chiesi (Italy) · ITAlmac (United Kingdom) · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchitis, ChronicPhosphodiesterase 4 InhibitorsPulmonary Disease, Chronic ObstructiveBiomarkersCyclic Nucleotide Phosphodiesterases, Type 4HumansInterleukin-8BiomarkersCyclic Nucleotide Phosphodiesterases, Type 4Interleukin-8Phosphodiesterase 4 Inhibitorsblood eosinophilschronic bronchitischronic obstructive pulmonary diseaseIL-8phosphodiesterase 4 inhibitors

Identifiers

PMID37192443
PMCPMC10492261
OpenAlexW4376637425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.